Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.1.023

Development and Validation of HPLC Method for Pharmacokinetic Study of Promethazine in Human  

Cho, Hae-Young (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Lee, Hwa-Jeong (College of Pharmacy, Ewha Womans University)
Choi, Hoo-Kyun (College of Pharmacy, Chosun University)
Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.1, 2006 , pp. 23-29 More about this Journal
Abstract
A rapid, selective and sensitive reversed-phase HPLC method for the determination of promethazine in human serum was developed, validated, and applied to the pharmacokinetic study of promethazine. Promethazine and internal standard, chlorpromazine, were extracted from human serum by liquid-liquid extraction with n-hexane containing 0.8% isopropanol and analyzed on a Capcell Pak CN column with the mobile phase of acetonitrile-0.2 M potassium dihydrogen phosphate (42:58, v/v, adjusted to pH 6.0 with 1 M NaOH). Detection wavelength of 251 nm and flow rate of 0.9 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^{3}$ factorial design using a fixed promethazine concentration (10 ng/mL) with respect to its peak area and retention time. In addition, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 1-40 ng/mL with correlation coefficients greater than 0.999. The lower limit of quantification using 1 mL of serum was 1 ng/mL, which was sensitive enough for pharmacokinetic studies. The overall accuracy of the quality control samples ranged from 96.15 to 105.40% for promethazine with overall precision (% C.V.) being 6.70-11.22%. The relative mean recovery of promethazine for human serum was 63.54%. Stability (freeze-thaw and short-term) studies showed that promethazine was stable during storage, or during the assay procedure in human serum. However, the storage at $-80^{\circ}C$ for 4 weeks showed that promethazine was not stable. Extracted serum sample and stock solution were not allowed to stand at ambient temperature for 12 hr prior to injection. The peak area and retention time of promethazine were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of promethazine in human serum samples for the pharmacokinetic studies of orally administered Himazin tablet (25 mg as promethazine hydrochloride) at three different laboratories, demonstrating the suitability of the method.
Keywords
Promethazine; Human serum; Validation; Pharmacokinetics; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 R. Zaman, I.L. Honigberg, GE. Francisco, J.A. Kotzan, J.T. Stewart, W.J. Brown, V.P. Shah and F.R. Pelsor, Bioequivalence and dose proportionality of three tablets promethazine products, Biopharm. Drug Dispos., 7(3), 281-291 (1986)   DOI   ScienceOn
2 $WinNonlin^{TM}$ Users Guide Ver. 3.0, Pharsight Corp. Mountain View, CA, USA (1998-1999)
3 G.J. DiGregorio and E.J. Ruch, Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine, J. Pharm. Sci., 69(12), 1457-1459 (1980)   DOI
4 G. Taylor, J.B. Houston, J. Shaffer and G. Mawer, Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man, Br. J. Clin. Pharmacol., 15(3), 287-293 (1983)   DOI   ScienceOn
5 R. Koytchev, R.G Alken, V. Kirkov, G Neshev, M. Vagaday and U. Kunter, Absolute bioavailability of chlorpromazine, promazine and promethazine, Arzneimittelforschung, 44(2), 121-125 (1994)
6 Martindale, The complete drug reference, 32 editions 1999, p. 416 (1999)
7 식품의약청안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22)
8 S.R. Vanapalli, S.P. Kambhampati, L. Putcha, D.W. Bourne, A liquid chromatographic method for the simultaneous determination of promethazine and three of its metabolites in plasma using electrochemical and UV detectors, J. Chromatogr. Sci., 39, 70-72 (2001)   DOI   ScienceOn